Atle 180 - internationalization & competence improvement
| Reference number | |
| Coordinator | Njord International AB |
| Funding from Vinnova | SEK 200 000 |
| Project duration | August 2023 - April 2024 |
| Status | Completed |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Skills enhancement in small businesses 2023 |
Important results from the project
- Mapped regulatory pathway into non-EU countries: UK, Switzerland, USA and Canada. - Created stronger market understanding for UK&I
Expected long term effects
- Mapping of needs and regulatory eligibility requirements in Great Britain has resulted in establishment of Njord Medtech Ltd in 2024 - Mapping of regulatory eligibility requirements in Switzerland has resulted in establishment in 2024 via CH-Rep MedEnvoy - Mapping of regulatory eligibility requirements in the USA and Canada completed, no decision taken yet.
Approach and implementation
** Denna text är maskinöversatt ** Commercial market analysis in the UK was carried out by an on-site consultant who has worked in the NHS for +30 years. Regulatory mapping of Atle 180 introduction in England, Switzerland, USA, Canada was carried out by experienced QA&RA consultant based in Sweden